[Upd-discuss] Access to Knowledge Treaty

James Love james.love@cptech.org
Wed, 26 Jan 2005 03:27:05 -0500


Countries could agree, as a condition of marketing approval for 
medicines, to have disclosures of all trials.

Interesting, the US and EU have, and are pushing everywhere, for a sui 
generis protection of data from trials.  This protection includes an 
exclusive right to rely upon  information from trials, even when no 
patents are involved.

jamie

Richard Stallman wrote:
> Another idea is to require publication of the detaila of drug studies,
> the information that drug companies like to keep secret.
> 
> Another idea is to forbid drug companies to have any control over the
> publication over any research results of research that they fund.
> 
> I wish I could think of a way to prevent them from punishing
> researchers who publish negative results by not funding them any more,
> but the only way I can see is for the government to tax these
> companies and fund the research directly.  That doesn't really fit
> the rubric of "access to knowledge".
> _______________________________________________
> Upd-discuss mailing list
> Upd-discuss@lists.essential.org
> http://lists.essential.org/mailman/listinfo/upd-discuss
> 
> 

-- 
James Love, Director, CPTech, http://www.cptech.org

Consumer Project on Technology in Washington, DC
PO Box 19367, Washington, DC 20036, USA
Tel.:  1.202.387.8030, fax: 1.202.234.5176

Consumer Project on Technology in Geneva
1 Route des  Morillons, CP 2100, 1211 Geneva 2, Switzerland
Tel: +41 22 791 6727

Mobile +1.202.361.3040
james.love@cptech.org